{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:01:53Z","timestamp":1787626913297,"version":"build-2736575974"},"reference-count":38,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,2,14]]},"abstract":"<jats:p>Wang et al. found that elderly COVID-19 patients were at risk of AD. The following facts suggest a possible explanation: reactivation of herpes simplex virus type 1 (HSV1) and other herpesviruses can occur in SARS-CoV-2 patients; in cell cultures, HSV1 infection causes occurrence of many AD-like features, as does reactivation of latent HSV1 after addition of certain infectious agents; recurrent experimental reactivation of HSV1-infected mice leads to formation of the main features of AD brains, and to cognitive decline. These suggest that COVID-19 results in repeated reactivation of HSV1 in brain, with subsequent accumulation of damage and eventual development of AD.<\/jats:p>","DOI":"10.3233\/jad-220955","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T11:35:04Z","timestamp":1672140904000},"page":"1273-1276","source":"Crossref","is-referenced-by-count":12,"title":["COVID-19 and Alzheimer\u2019s Disease: What Is the Connection?"],"prefix":"10.1177","volume":"91","author":[{"given":"Ruth F.","family":"Itzhaki","sequence":"first","affiliation":[{"name":"Institute of Population Ageing, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220955_ref1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-220717","article-title":"Association of COVID-19 with new-onset Alzheimer\u2019s disease","volume":"89","author":"Wang","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220955_ref2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s12028-020-01049-4","article-title":"Neurological involvement in COVID-19 and potential mechanisms: A review","volume":"34","author":"Aghagoli","year":"2021","journal-title":"Neurocrit Care"},{"key":"10.3233\/JAD-220955_ref3","doi-asserted-by":"crossref","DOI":"10.1177\/15333175221078418","article-title":"SARS-CoV-2-mediated neuropathogenesis, deterioration of hippocampal neurogenesis and dementia","volume":"37","author":"Radhakrishnan","year":"2022","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3233\/JAD-220955_ref4","doi-asserted-by":"crossref","first-page":"e2200960119","DOI":"10.1073\/pnas.2200960119","article-title":"Morphological, cellular, and molecularbasis of brain infection in COVID-19 patients","volume":"119","author":"Crunfli","year":"2022","journal-title":"Proc Natl AcadSci U S A"},{"key":"10.3233\/JAD-220955_ref5","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.3390\/ijms22147263","article-title":"Activation of endogenous retrovirus, brain infections and environmental insults in neurodegeneration and Alzheimer\u2019s disease","volume":"22","author":"Licastro","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-220955_ref6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s13054-020-03252-3","article-title":"Herpes simplex virus and cytomegalovirus reactivationsamong severe COVID-19 patients","volume":"24","author":"Le Balc\u2019h","year":"2020","journal-title":"Crit Care"},{"key":"10.3233\/JAD-220955_ref7","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3390\/microorganisms9091896","article-title":"Herpes simplex virus re-activation inpatients with SARS-CoV-2 pneumonia: A prospective, observationalstudy","volume":"9","author":"Franceschini","year":"2021","journal-title":"Microorganisms"},{"key":"10.3233\/JAD-220955_ref8","doi-asserted-by":"crossref","first-page":"e2248","DOI":"10.1002\/rmv.2248","article-title":"Oral manifestations of Covid-19-A literature review","volume":"32","author":"Farid","year":"2022","journal-title":"Rev Med Virol"},{"key":"10.3233\/JAD-220955_ref9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s11845-021-02714-z","article-title":"Herpes simplex and herpes zoster viruses in COVID-19 patients","volume":"191","author":"Katz","year":"2022","journal-title":"Ir J Med Sci"},{"key":"10.3233\/JAD-220955_ref10","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1002\/jmv.27994","article-title":"SARS-CoV-2 infection and lytic reactivation of herpesviruses: A potential threat in the postpandemic era?","volume":"94","author":"Chen","year":"2022","journal-title":"J Med Virol"},{"key":"10.3233\/JAD-220955_ref11","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s40121-022-00674-0","article-title":"Herpessimplex virus 1 (HSV-1) reactivation in critically ill COVID-19 patients: A brief narrative review","volume":"11","author":"Giacobbe","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.3233\/JAD-220955_ref12","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2174\/1570159X15666170313122937","article-title":"The infectious etiology of Alzheimer\u2019s disease","volume":"15","author":"Sochocka","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-220955_ref13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-191337","article-title":"Associations of infectious agents with Alzheimer\u2019s disease: A systematic review and metaanalysis","volume":"75","author":"Ou","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220955_ref14","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S1473-3099(21)00144-4","article-title":"Hospital-treated infectious diseases and the risk of dementia: A large, multicohort, observational study with a replication cohort","volume":"21","author":"Sipil\u00e4","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.3233\/JAD-220955_ref15","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1007\/s10072-022-06280-9","article-title":"Infectious diseases and cognition: Do we have to worry?","volume":"22","author":"Hernandez-Ruiz","year":"2022","journal-title":"Neurol Sci"},{"key":"10.3233\/JAD-220955_ref16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00406-021-01286-4","article-title":"Cognitive decline following acute viral infections: Literature review and projections for post-COVID-19","volume":"272","author":"Damiano","year":"2022","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.3233\/JAD-220955_ref17","doi-asserted-by":"crossref","first-page":"e1004092","DOI":"10.1371\/journal.pmed.1004092","article-title":"Hospital-treated infections in early- and mid-life and risk of Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden","volume":"19","author":"Sun","year":"2022","journal-title":"PLoS Med"},{"key":"10.3233\/JAD-220955_ref18","first-page":"1495","article-title":"Past exposure to vaccines and subsequent risk of Alzheimer\u2019s disease","volume":"165","author":"Verreault","year":"2001","journal-title":"CMAJ"},{"key":"10.3233\/JAD-220955_ref19","doi-asserted-by":"crossref","first-page":"e045871","DOI":"10.1136\/bmjopen-2020-045871","article-title":"Shingles, Zostavax vaccination and risk of developing dementia: A nested case-control study-results from the UK Biobank cohort","volume":"11","author":"Lophatananon","year":"2021","journal-title":"BMJ Open"},{"key":"10.3233\/JAD-220955_ref20","doi-asserted-by":"crossref","first-page":"101534","DOI":"10.1016\/j.arr.2021.101534","article-title":"Influenza vaccination reduces dementia risk: A systematic review and meta-analysis","volume":"73","author":"Veronese","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-220955_ref21","doi-asserted-by":"crossref","first-page":"872542","DOI":"10.3389\/fimmu.2022.872542","article-title":"Adult vaccination as a protective factor for dementia: A meta-analysis and systematic review of population-based observational studies","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"10.3233\/JAD-220955_ref22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2007.09.077","article-title":"Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation","volume":"429","author":"Wozniak","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-220955_ref23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2009-0963","article-title":"Alzheimer\u2019s disease-specific tau phosphorylation is induced by herpes simplex virus type 1","volume":"16","author":"Wozniak","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220955_ref24","doi-asserted-by":"crossref","first-page":"eaay8828","DOI":"10.1126\/sciadv.aay8828","article-title":"A 3D human brain-like tissue model of herpes-induced Alzheimer\u2019s disease","volume":"6","author":"Cairns","year":"2020","journal-title":"Sci Adv"},{"key":"10.3233\/JAD-220955_ref25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3233\/JAD-220287","article-title":"Potential involvement of varicella zoster virus in Alzheimer\u2019s disease via reactivation of quiescent herpes simplex virus type 1","volume":"88","author":"Cairns","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220955_ref26","doi-asserted-by":"crossref","first-page":"e1007617","DOI":"10.1371\/journal.ppat.1007617","article-title":"Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice","volume":"15","author":"De Chiara","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.3233\/JAD-220955_ref27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1017\/S0317167100044115","article-title":"Limbic predilection in Alzheimer dementia: Is reactivated herpesvirus involved?","volume":"9","author":"Ball","year":"1982","journal-title":"Can J Neurol Sci"},{"key":"10.3233\/JAD-220955_ref28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jmv.1890330403","article-title":"Latent herpes simplex virus type 1 in normal and Alzheimer\u2019s disease brains","volume":"33","author":"Jamieson","year":"1991","journal-title":"J Med Virol"},{"key":"10.3233\/JAD-220955_ref29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/jnnp.49.6.613","article-title":"Detection of HSV1 DNA by in situ hybridisation in human brain after immunosuppression","volume":"49","author":"Saldanha","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-220955_ref30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","article-title":"Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease","volume":"349","author":"Itzhaki","year":"1997","journal-title":"Lancet"},{"key":"10.3233\/JAD-220955_ref31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13311-018-0611-x","article-title":"Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections-a nationwide, population-based cohort study in Taiwan","volume":"15","author":"Tzeng","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.3233\/JAD-220955_ref32","doi-asserted-by":"crossref","first-page":"e31116","DOI":"10.1097\/MD.0000000000031116","article-title":"Increased incidence of dementia following herpesvirus infection in the Korean population","volume":"101","author":"Shim","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.3233\/JAD-220955_ref33","doi-asserted-by":"crossref","first-page":"e12119","DOI":"10.1002\/trc2.12119","article-title":"Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden","volume":"7","author":"Lopatko Lindman","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-220955_ref34","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/ene.14795","article-title":"Antiherpetic medication and incident dementia: Observational cohort studies in four countries","volume":"28","author":"Schnier","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-220955_ref35","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1038\/s41598-021-87963-9","article-title":"Herpes simplex virus 1 and the risk of dementia: A population-based study","volume":"11","author":"Murphy","year":"2021","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-220955_ref36","first-page":"13","article-title":"Alzheimer\u2019s disease and herpes","volume":"167","author":"Itzhaki","year":"2002","journal-title":"CMAJ"},{"key":"10.3233\/JAD-220955_ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2151","article-title":"Does bacillus Calmette-Guerin vaccine prevent herpes simplex virus recurrences? A systematic review","volume":"31","author":"Pittet","year":"2021","journal-title":"Rev Med Virol"},{"key":"10.3233\/JAD-220955_ref38","doi-asserted-by":"crossref","first-page":"861956","DOI":"10.3389\/fnagi.2022.861956","article-title":"BacillusCalmette-Gu\u00e9rin in immuno-regulation of Alzheimer\u2019s disease","volume":"14","author":"Klein","year":"2022","journal-title":"Front Aging Neurosci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:07Z","timestamp":1777370827000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":38,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-220955","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]}}}